Wbi Investments, Inc. Viatris Inc Transaction History

Wbi Investments, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$11.27 - $13.53 $2.96 Million - $3.55 Million	-262,321 Reduced 67.64%	125,494 $1.5 Million
Q4 2023 Feb 09, 2024	BUY	$8.77 - $10.85 $1.61 Million - $1.99 Million	183,747 Added 90.04%	387,815 $4.2 Million
Q3 2023 Nov 09, 2023	SELL	$9.59 - $11.35 $1.08 Million - $1.28 Million	-112,886 Reduced 35.62%	204,068 $2.01 Million
Q2 2023 Aug 07, 2023	SELL	$9.02 - $10.29 $1.31 Million - $1.5 Million	-145,467 Reduced 31.46%	316,954 $3.16 Million
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $4.02 Million - $5.36 Million	437,327 Added 1742.76%	462,421 $4.45 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $64,310 - $85,255	7,375 Added 41.62%	25,094 $279,000
Q3 2022 Oct 26, 2022	BUY	$8.48 - $11.13 $150,257 - $197,212	17,719 New	17,719 $138,000
Q2 2022 Jul 25, 2022	SELL	$9.95 - $12.27 $817,850 - $1.01 Million	-82,196 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$9.81 - $15.4 $806,342 - $1.27 Million	82,196 New	82,196 $894,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Wbi Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Wbi Investments, Inc. with notifications on news.